Does Cosentyx (secukinumab) reduce how well vaccines work?
Cosentyx (secukinumab) blocks interleukin-17A (IL-17A). Because it is not a broad immunosuppressant, it is generally expected to have a less pronounced effect on vaccine responses than therapies that more strongly suppress immune function. The key practical issue is which type of vaccine is being used (live vs non-live), not just the presence of Cosentyx.
For this question specifically, the provided information does not include data on how Cosentyx changes vaccine effectiveness or immunogenicity in vaccinated patients.
Live vaccines vs non-live vaccines while on Cosentyx
The main vaccine-related safety distinction for biologics like Cosentyx is usually whether a vaccine is live or non-live. Live vaccines typically raise more concern in people taking immune-modifying therapies, while non-live (inactivated or subunit) vaccines are generally preferred.
However, the provided information does not state Cosentyx-specific guidance (for example, whether live vaccines should be avoided or timing rules for dosing around vaccination).
If I’m on Cosentyx, should I time vaccinations before starting treatment?
When guidance is available, clinicians often recommend giving needed vaccines before starting an immune-modifying drug when possible, and coordinating timing around dosing.
The provided information does not include Cosentyx-specific timing recommendations (such as how long before the first dose to vaccinate, or how long to wait after a dose).
What happens if I get a flu/COVID-19 vaccine while taking Cosentyx?
For most immune-modifying conditions and therapies, non-live vaccines (like flu shots and most COVID-19 vaccines) are commonly used during treatment, but the extent of immune response can vary by drug class and patient factors.
The provided information does not provide Cosentyx-specific effects on the immune response to flu, COVID-19, or other common vaccines.
Where to find the exact vaccine-effectiveness evidence for Cosentyx
To answer “what are the effects on vaccine effectiveness” precisely, you would look for clinical studies that measure:
- vaccine antibody titers or seroprotection rates after vaccination, and/or
- real-world vaccine breakthrough outcomes,
- broken out by vaccine type (influenza, COVID-19, pneumococcal, etc.) and timing relative to dosing.
The provided information does not include any such study results for Cosentyx.
---
Sources
No sources were provided in the prompt, so I cannot cite evidence about Cosentyx and vaccine effectiveness.